Watchlist Price Alert

Fate Therapeutics Inc. (FATE)

NASDAQ: FATE · Real-Time Price · USD

1.23

-0.04 (-3.53%)

At close: Jun 16, 2025, 3:59 PM

1.26

2.44%

Pre-market: Jun 17, 2025, 09:00 AM EDT

Fate Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	13.63M	63.53M	96.3M	55.85M	31.43M	10.68M	4.74M	4.11M	4.4M
Cost of Revenue	n/a	161.7M	13.76M	5.85M	125.62M	87.77M	56.02M	34.36M	26.45M
Gross Profit	13.63M	-98.16M	82.54M	50M	-94.19M	-77.09M	-51.28M	-30.25M	-22.05M
Operating Income	-210.28M	-190.51M	-308.39M	-216.99M	-128.09M	-100.73M	-67.09M	-42.13M	-31.96M
Interest Income	17.29M	17.19M	5.84M	1.31M	2.4M	4.33M	2.19M	559K	138K
Pretax Income	-186.26M	-160.93M	-281.72M	-212.15M	-173.39M	-98.15M	-66.6M	-42.95M	-33.46M
Net Income	-186.26M	-160.93M	-255.06M	-206.3M	-170.3M	-97.71M	-66.6M	-42.95M	-33.46M
Selling & General & Admin	74.17M	81.45M	84.23M	57.32M	33.9M	23.64M	15.81M	11.87M	9.91M
Research & Development	135M	172.6M	320.45M	215.52M	125.62M	87.77M	56.02M	34.36M	26.45M
Other Expenses	14.74M	n/a	20.82M	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	223.91M	254.04M	404.69M	272.84M	159.52M	111.41M	71.83M	46.23M	36.37M
Interest Expense	n/a	n/a	5.84M	n/a	n/a	1.75M	1.7M	1.27M	1.64M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	223.91M	254.04M	404.69M	272.84M	159.52M	111.41M	71.83M	46.23M	36.37M
Income Tax Expense	n/a	n/a	-26.66M	-5.85M	-3.09M	-441K	2.19M	297K	-743K
Shares Outstanding (Basic)	113.69M	98.41M	96.83M	94.75M	82.39M	68.19M	56.2M	41.98M	31.75M
Shares Outstanding (Diluted)	113.69M	98.41M	96.83M	94.75M	82.39M	68.19M	56.2M	41.98M	31.75M
EPS (Basic)	-1.64	-1.64	-2.63	-2.18	-2.07	-1.43	-1.19	-1.02	-1.05
EPS (Diluted)	-1.64	-1.64	-2.63	-2.18	-2.07	-1.43	-1.19	-1.02	-1.05
EBITDA	-176.58M	-172.23M	-294.63M	-211.14M	-125M	-94.2M	-63.7M	-40.71M	-30.94M
EBIT	-195.54M	-190.51M	-308.39M	-216.99M	-128.09M	-96.4M	-64.9M	-41.68M	-31.82M
Depreciation & Amortization	18.96M	18.28M	13.76M	5.85M	3.09M	2.19M	1.2M	971K	881K